EQIS CAPITAL MANAGEMENT, INC. – Regeneron Pharmaceuticals, Inc. Transaction History
EQIS CAPITAL MANAGEMENT, INC. portfolio value:
$1.51M
portfolio value
EQIS CAPITAL MANAGEMENT, INC. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +11.77% | 232 shares | 352.51K | $688.87 | 2.20K |
| Q2 2022 | share | Decrease | -6.68% | -141 shares | -309.76K | $591.13 | 1.97K |
| Q1 2022 | share | Increase | +11.22% | 213 shares | 276K | $698.42 | 2.11K |
| Q4 2021 | share | Increase | +2.65% | 49 shares | 80K | $642.51 | 1.89K |
| Q3 2021 | share | Decrease | -4.24% | -82 shares | 40K | $605.18 | 1.85K |
| Q2 2021 | share | Decrease | -3.01% | -60 shares | 137K | $558.54 | 1.93K |
| Q1 2021 | share | Decrease | -36.80% | -1.16K shares | -581K | $473.14 | 1.99K |
| Q4 2020 | share | Decrease | -23.10% | -947 shares | -771K | $483.11 | 3.15K |
| Q3 2020 | share | Increase | +3.33% | 132 shares | -180K | $559.78 | 4.09K |
| Q2 2020 | share | Decrease | -18.39% | -894 shares | 618K | $623.65 | 3.96K |
| Q1 2020 | share | Increase | +1.67% | 80 shares | 61K | $488.29 | 4.86K |
| Q4 2019 | share | Decrease | -9.19% | -484 shares | 335K | $375.48 | 4.78K |
| Q3 2019 | share | Decrease | -14.33% | -881 shares | -464K | $277.4 | 5.26K |
| Q2 2019 | share | Decrease | -6.55% | -431 shares | -777K | $313 | 6.14K |
| Q1 2019 | share | Decrease | -3.93% | -269 shares | 144K | $410.62 | 6.57K |
| Q4 2018 | share | Decrease | -17.49% | -1.45K shares | -794K | $373.5 | 6.84K |
| Q3 2018 | share | Increase | +13.08% | 960 shares | 820K | $404.04 | 8.29K |
| Q2 2018 | share | Increase | +131.74% | 4.17K shares | 1.44M | $344.99 | 7.33K |
| Q1 2018 | share | Increase | +2.43% | 75 shares | -72K | $344.36 | 3.16K |
| Q4 2017 | share | Increase | +1.95% | 59 shares | -194K | $375.96 | 3.09K |
| Q3 2017 | share | Decrease | -4.62% | -147 shares | -205K | $447.12 | 3.03K |
| Q2 2017 | share | Increase | +1.21% | 38 shares | 344K | $491.14 | 3.17K |
| Q1 2017 | share | Decrease | -11.47% | -407 shares | -86K | $387.51 | 3.14K |
| Q4 2016 | share | Decrease | -20.41% | -910 shares | -489K | $367.09 | 3.54K |
| Q3 2016 | share | Decrease | -2.13% | -97 shares | 201K | $402.02 | 4.45K |
| Q2 2016 | share | Increase | +4.52% | 197 shares | 20K | $349.23 | 4.55K |
| Q1 2016 | share | Decrease | -13.39% | -674 shares | -1.16M | $360.44 | 4.35K |